In addition, the role of TIM-3 in chronic lymphocytic leukemia (CLL) and certain lymphomas has been gradually gaining attention, but more mechanistic and clinical studies are needed to clarify the specific role played by TIM3 and to confirm the clinical value of TIM3. The gene discussed is HAVCR2; the disease is lymphoma.